Completed PHASE4 INTERVENTIONAL 1-arm NCT00500071

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD

A Prospective, Open-Label, Multi-Center, Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) 20-70mg in Children Aged 6-12 Diagnosed With ADHD

Sponsor: Shire

Conditions Attention Deficit Hyperactivity Disorder (ADHD)

Interventions Vyvanse (lisdexamfetamine dimesylate)

Updated 8 times since 2017 Last updated: Feb 25, 2022 Started: Jun 28, 2007 Primary completion: Jan 2, 2008 Completion: Jan 2, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Attention Deficit Hyperactivity Disorder (ADHD), this trial is completed. The trial is conducted by Shire and has accumulated 8 data snapshots since 2007. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Study Description(click to expand)

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (lisdexamfetamine dimesylate) in Children aged 6-12 Diagnosed with ADHD

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Apr 2022 — Jul 2024 [monthly]

Completed PHASE4
Sep 2021 — Apr 2022 [monthly]

Completed PHASE4
Jan 2021 — Sep 2021 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shire

Data source: Takeda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austin, United States , Bardstown, United States , Bellaire, United States , Charlotte, United States , Cleveland, United States , Durham, United States , El Centro, United States , Eugene, United States , Gainesville, United States , Herndon, United States and 35 more locations